Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: A prospective cohort study

The Lancet Infectious Diseases

Volumn 16, Issue 3, 2016, Pages 339-347

  Bijlsma, Merijn W ^a   Brouwer, Matthijs C ^a   Kasanmoentalib, E Soemirien ^a   Kloek, Anne T ^a   Lucas, Marjolein J ^a   Tanck, Michael W ^a   van der Ende, Arie ^a,b   van de Beek, Diederik ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; C REACTIVE PROTEIN; CEPHALOSPORIN; DEXAMETHASONE; ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOLISM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BLOOD CULTURE; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; CRANIAL NERVE PARALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; ENDOCARDITIS; EPIDEMIC MENINGITIS; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HUMAN; INCIDENCE; LIQUORRHEA; LISTERIOSIS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MIDDLE AGED; NETHERLANDS; NONHUMAN; OTITIS; OUTCOME ASSESSMENT; PNEUMOCOCCAL MENINGITIS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINUSITIS; STREPTOCOCCUS PNEUMONIAE; TACHYCARDIA; TREATMENT DURATION; ADOLESCENT; BACTERIUM; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; ISOLATION AND PURIFICATION; MENINGITIS, BACTERIAL; MICROBIOLOGY; ODDS RATIO; SEROTYPE; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BACTERIA; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DEXAMETHASONE; FEMALE; HUMANS; INCIDENCE; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; NETHERLANDS; ODDS RATIO; SEROGROUP; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84959139473     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00430-2     Document Type: Article

References (42)

1. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004, 351:1849-1859.
2. McIntyre PB, O'Brien KL, Greenwood B, van de Beek D Effect of vaccines on bacterial meningitis worldwide. Lancet 2012, 380:1703-1711.
3. van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR Advances in treatment of bacterial meningitis. Lancet 2012, 380:1693-1702.
4. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011, 364:2016-2025.
5. de Gans J, van de Beek D Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002, 347:1549-1556.
6. van de Beek D, de Gans J Dexamethasone in adults with community-acquired bacterial meningitis. Drugs 2006, 66:415-427.
7. van de Beek D Progress and challenges in bacterial meningitis. Lancet 2012, 380:1623-1624.
8. Brouwer MC, Heckenberg SG, de Gans J, Spanjaard L, Reitsma JB, van de Beek D Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010, 75:1533-1539.
9. Heckenberg SG, Brouwer MC, van der Ende A, Hensen EF, van de Beek D Hearing loss in adults surviving pneumococcal meningitis is associated with otitis and pneumococcal serotype. Clin Microbiol Infect 2012, 18:849-855.
10. Lucas MJ, Brouwer MC, van de Beek D Delayed cerebral thrombosis in bacterial meningitis: a prospective cohort study. Intensive Care Med 2013, 39:866-871.
11. Lucas MJ, Brouwer MC, van der Ende A, van de Beek D Outcome in patients with bacterial meningitis presenting with a minimal Glasgow Coma Scale score. Neurol Neuroimmunol Neuroinflamm 2014, 1:e9.
12. Lucas MJ, Brouwer MC, van der Ende A, van de Beek D Endocarditis in adults with bacterial meningitis. Circulation 2013, 127:2056-2062.
13. Adriani KS, Brouwer MC, van der Ende A, van de Beek D Bacterial meningitis in adults after splenectomy and hyposplenic states. Mayo Clin Proc 2013, 88:571-578.
14. Woehrl B, Brouwer MC, Murr C, et al. Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. J Clin Invest 2011, 121:3943-3953.
15. Brouwer MC, Meijers JC, Baas F, et al. Plasminogen activator inhibitor-1 influences cerebrovascular complications and death in pneumococcal meningitis. Acta Neuropathol 2014, 127:553-564.
16. Mook-Kanamori BB, Valls Seron M, Geldhoff M, et al. Thrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis. J Thromb Haemost 2015, 13:2076-2086.
17. Piet JR, Geldhoff M, van Schaik BD, et al. Streptococcus pneumoniae arginine synthesis genes promote growth and virulence in pneumococcal meningitis. J Infect Dis 2014, 209:1781-1791.
18. Heckenberg SG, Brouwer MC, van der Ende A, van de Beek D Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology 2012, 79:1563-1569.
19. Koopmans MM, Brouwer MC, Bijlsma MW, et al. Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. Clin Infect Dis 2013, 57:247-253.
20. Spanjaard L, Bol P, Ekker W, Zanen HC The incidence of bacterial meningitis in the Netherlands-a comparison of three registration systems, 1977-1982. J Infect 1985, 11:259-268.
21. Bijlsma MW, Bekker V, Brouwer MC, Spanjaard L, van de Beek D, van der Ende A Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data. Lancet Infect Dis 2014, 14:805-812.
22. Spanos A, Harrell FE, Durack DT Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA 1989, 262:2700-2707.
23. van de Beek D, Drake JM, Tunkel AR Nosocomial bacterial meningitis. N Engl J Med 2010, 362:146-154.
24. Jennett B, Teasdale G Management of head injuries 1981, F A Davis, Philadelphia. 2 edn.
25. van de Beek D, de Gans J, Spanjaard L, Vermeulen M, Dankert J Antibiotic guidelines and antibiotic use in adult bacterial meningitis in the Netherlands. J Antimicrob Chemother 2002, 49:661-666.
26. Spanjaard L, Bol P, Zanen HC Non-neonatal meningitis due to less common bacterial pathogens, the Netherlands, 1975-83. J Hyg (Lond) 1986, 97:219-228.
27. Mulder CJ, Zanen HC A study of 280 cases of neonatal meningitis in the Netherlands. J Infect 1984, 9:177-184.
28. van de Beek D, Brouwer MC, de Gans J, et al. Richtlijn bacteriele meningitis 2013, Nederlandse Vereniging voor Neurologie, Utrecht.
29. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009, 6:e1000081.
30. Jansen AG, Rodenburg GD, van der Ende A, et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis 2009, 49:e23-e29.
31. van Deursen AM, van Mens SP, Sanders EA, et al. Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis 2012, 18:1729-1737.
32. Rodenburg GD, de Greeff SC, Jansen AG, et al. Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis 2010, 16:816-823.
33. Kaaijk P, van der Ende A, Berbers G, van den Dobbelsteen GP, Rots NY Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? Experience from the Netherlands. BMC Infect Dis 2012, 12:35.
34. Bijlsma MW, Brouwer MC, Spanjaard L, van de Beek D, van der Ende A A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination. Clin Infect Dis 2014, 59:1216-1221.
35. Brouwer MC, McIntyre P, Prasad K, van de Beek D Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2015, 9:CD004405.
36. van de Beek D, de Gans J, McIntyre P, Prasad K Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis 2004, 4:139-143.
37. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993, 328:21-28.
38. Adriani KS, van de Beek D, Brouwer MC, Spanjaard L, de Gans J Community-acquired recurrent bacterial meningitis in adults. Clin Infect Dis 2007, 45:e46-e51.
39. Tebruegge M, Curtis N Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis. Clin Microbiol Rev 2008, 21:519-537.
40. Brouwer MC, Tunkel AR, van de Beek D Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010, 23:467-492.
41. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF Community-acquired bacterial meningitis in adults. N Engl J Med 2006, 354:44-53.
42. Ricard JD, Wolff M, Lacherade JC, et al. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 2007, 44:250-255.